Lipid lowering treatment after percutaneous coronary intervention: data from the large contemporary ZON-HR registry.

Back

ESC Professional Premium Access

Lipid lowering treatment after percutaneous coronary intervention: data from the large contemporary ZON-HR registry.

Session: Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Topic: Primary Percutaneous Coronary Intervention (PCI)

Speaker: Ms E. Woelders (Nijmegen, NL)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Ms Eva Christine Ida Woelders

Radboud University Medical Centre, Nijmegen (Netherlands (The))

0 follower

4 more presentations in this session

State-of-the-art lecture beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Speaker: Professor S. Nicholls (Melbourne, AU)

Access

Slides

Video

Bivalirudin versus Heparin in ST and non-ST-segment elevation myocardial infarction

Speaker: Professor E. Omerovic (Gothenburg, SE)

P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis

Speaker: Professor J. Silvain (Paris, FR)

Successful ESC recommended LDL-C reduction after percutaneous coronary intervention: real-world data from the contemporary ZON-HR registry.

Speaker: Ms D. Peeters (Nijmegen, NL)

Access the full session

Beyond antithrombotic therapies in PCI: role of lipids, inflammation, and therapies on the horizon

Speakers: Ms E. Woelders, Professor S. Nicholls, Professor E. Omerovic, Professor J. Silvain, Ms D. Peeters

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources